Skip to main content

More than 100 stakeholder groups call on US Congress leadership to reauthorize PAHPA

Center News

Published

November 14, 2023 Today, more than 100 stakeholders, including the Johns Hopkins Center for Health Security, Biotechnology Innovation Organization (BIO), Association of State and Territorial Health Officials (ASTHO), and other groups representing academia, industry, and research institutes, sent a letter to congressional leadership urging them to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) before the end of the calendar year and with the same bipartisan support it has had since its original authorization 17 years ago.

Led by the Johns Hopkins Center for Health Security, the coalition called on Senate Majority Leader Charles Schumer, Senate Minority Leader Mitch McConnell, House Speaker Mike Johnson, and House Minority Leader Hakeem Jeffries to include a comprehensive 5-year PAHPA reauthorization in moving legislation this year.

“Our nation’s changing health security threat landscape and the federal government’s responsibility to protect the American people demand that we work together now to find a strong bipartisan path forward to reauthorize this critical legislation,” write the signatories. “Failing to reauthorize PAHPA would have serious effects on our country’s economic well-being, national security, and health security given the rapidly changing threat landscape.”

Read the full letter.
Read the updated letter from January 16, 2024, with additional signatories.

Signatories, in alphabetical order:

  • 1Day Sooner

    3M*

    Acadian Ambulance Service, Inc.

    Adaptive Phage Therapeutics
  • AdvaMed*

    Aequor Inc.
  • Alliance for Biosecurity*

    Altor Safety*

    America’s Essential Hospitals
  • American Ambulance Association

    American Association of Neurological Surgeons*

    American Clinical Laboratory Association*

    American College of Emergency Physicians

    American College of Surgeons

    American Hospital Association

    American Lung Association

    American Medical Manufacturers Association (AMMA)*
  • American Pharmacies

    American Public Health Association

    American Society for Microbiology
  • Arizona Bioindustry Association, Inc. (AZBio)

    Association for Professionals in Infection Control and Epidemiology

    Association of American Medical Colleges*

    Association of Maternal & Child Health Programs

    Association of Public Health Laboratories*

    Association of State and Territorial Health Officials

    Asthma and Allergy Foundation of America

    AstraZeneca Pharmaceuticals

    ATCC

    Atea Pharmaceuticals, Inc.

    Bavarian Nordic
  • Big Cities Health Coalition

    Biocom California*

    BioCT  

    BioForward Wisconsin

    BioKansas

    BioNJ

    Biotechnology Innovation Organization (BIO)
  • Bugworks

    Cencora

    Civitas Networks for Health*
  • Colorado BioScience Association

    CommonSpirit Health*

    Congress of Neurological Surgeons*

    Council of State and Territorial Epidemiologists

    Council of State Bioscience Associations (CSBA)

    CSL Seqirus

    Emergency Department Practice Management Association

    Emergent BioSolutions

    FAH*

    Federation of American Scientists

    FluGen Inc.
  • Georgia Bio

    Gerontological Society of America

    Ginkgo Bioworks

    Global Health Investment Corporation

    Global Health Technologies Coalition

    Gryphon Scientific

    GSK
  • Health Industry Distributors Association (HIDA)

    Healthcare Distribution Alliance

    Healthcare Leadership Council

    Healthcare Ready
  • Helix

    HIMSS

    HIV Medicine Association

    IAVI

    Illinois Biotechnology Innovation Organization

    Indiana Health Industry Forum*
  • Infectious Diseases Society of America

    INOVIO Pharmaceuticals

    Institute for Progress

    Johns Hopkins Center for Health Security
  • Life Sciences PA

    Locus Biosciences
  • Mallinckrodt

    Marked By Covid

    Mass General Brigham*

    MassBio

    McKesson

    Medical Alley

    Medical Countermeasures Coalition

    Missouri Biotechnology Association (MOBIO)
  • Morehouse School of Medicine - Atlanta, GA*

    Mount Sinai Health System*

    National Association of County and City Health Officials

    National Immigration Law Center

    NC Life Sciences Organization*
  • New Mexico Biotechnoiogy & Biomedical Association (NMBio)

    New Orleans BioInnovation Center

    NewYorkBIO
  • NightHawk Biosciences

    Novavax

    Ochsner Health

    Ohio Life Sciences Association

    Oklahoma Bioscience Association

    PDS Biotechnology

    PharmaJet Inc.

    Premier Inc.

    Public Health Accreditation Board

    READDI Inc.*
  • RS BioTherapeutics, Inc.

    SAB Biotherapeutics, Inc.
  • Sanofi

    SecureBio

    Shionogi Inc.

    SIGA Technologies, Inc.

    Society for Public Health Education

    Soligenix, Inc.

    Technologies for Pandemic Defense

    Texas A&M Health Science Center*

    Texas Healthcare & Bioscience Institute
  • Trauma Anesthesiology Society

    Trinity Health

    TrippBio, Inc.
  • Trust for America’s Health

    United Safety Technology Inc*

    United States Pharmacopeia (USP)
  • University of Hawaii

    University of Maryland School of Medicine
  • Valneva USA

    Vaxess Technologies*

    Vaxxas Inc

    Virginia Biotechnology Association

    Washington State University*

* Denotes signatures added on January 16, 2024.